- Home
- ADCT vs ZJYL Comparison
ADCT vs ZJYL Comparison
Compare ADCT & ZJYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- ZJYL
- Stock Information
- Founded
- ADCT 2011
- ZJYL 2006
- Country
- ADCT Switzerland
- ZJYL China
- Employees
- ADCT N/A
- ZJYL N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- ZJYL Industrial Specialties
- Sector
- ADCT Health Care
- ZJYL Consumer Discretionary
- Exchange
- ADCT Nasdaq
- ZJYL Nasdaq
- Market Cap
- ADCT 143.1M
- ZJYL 127.4M
- IPO Year
- ADCT 2020
- ZJYL 2023
- Fundamental
- Price
- ADCT $1.49
- ZJYL $0.70
- Analyst Decision
- ADCT Strong Buy
- ZJYL
- Analyst Count
- ADCT 5
- ZJYL 0
- Target Price
- ADCT $8.50
- ZJYL N/A
- AVG Volume (30 Days)
- ADCT 344.2K
- ZJYL 325.8K
- Earning Date
- ADCT 03-27-2025
- ZJYL 05-03-2025
- Dividend Yield
- ADCT N/A
- ZJYL N/A
- EPS Growth
- ADCT N/A
- ZJYL 18.46
- EPS
- ADCT N/A
- ZJYL 0.02
- Revenue
- ADCT $70,837,000.00
- ZJYL $23,502,010.00
- Revenue This Year
- ADCT $6.81
- ZJYL N/A
- Revenue Next Year
- ADCT $11.24
- ZJYL N/A
- P/E Ratio
- ADCT N/A
- ZJYL $30.29
- Revenue Growth
- ADCT 1.84
- ZJYL 18.57
- 52 Week Low
- ADCT $1.39
- ZJYL $0.59
- 52 Week High
- ADCT $5.38
- ZJYL $4.65
- Technical
- Relative Strength Index (RSI)
- ADCT 39.46
- ZJYL 42.91
- Support Level
- ADCT $1.41
- ZJYL $0.66
- Resistance Level
- ADCT $1.68
- ZJYL $0.74
- Average True Range (ATR)
- ADCT 0.12
- ZJYL 0.09
- MACD
- ADCT -0.03
- ZJYL -0.02
- Stochastic Oscillator
- ADCT 16.00
- ZJYL 12.13
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.
About ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.